切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2023, Vol. 19 ›› Issue (05) : 611 -615. doi: 10.3877/cma.j.issn.1673-5250.2023.05.016

综述

妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系
周梦玲, 薛志伟, 周淑()   
  1. 四川大学华西第二医院产科、出生缺陷与相关妇儿疾病教育部重点实验室,成都 610041;成都市双流区妇幼保健院产科,成都 610299
    四川大学华西第二医院产科、出生缺陷与相关妇儿疾病教育部重点实验室,成都 610041
  • 收稿日期:2023-06-01 修回日期:2023-09-10 出版日期:2023-10-01
  • 通信作者: 周淑

Changes in size of uterine myoma during pregnancy and its association with adverse pregnancy outcomes

Mengling Zhou, Zhiwei Xue, Shu Zhou()   

  1. Department of Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China; Department of Obstetrics, Chengdu Shuangliu District Maternity and Child Health Care Hospital, Chengdu 610299, Sichuan Province, China
    Department of Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2023-06-01 Revised:2023-09-10 Published:2023-10-01
  • Corresponding author: Shu Zhou
  • Supported by:
    National Key Research and Development Project(2018YFC1004603)
引用本文:

周梦玲, 薛志伟, 周淑. 妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 611-615.

Mengling Zhou, Zhiwei Xue, Shu Zhou. Changes in size of uterine myoma during pregnancy and its association with adverse pregnancy outcomes[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 611-615.

子宫肌瘤(UM)是女性生殖道最常见良性肿瘤,好发于育龄期,病因迄今尚未阐明,其发生、发展可能与雌、孕激素等相关。虽然孕期胎盘产生雌、孕激素水平随着孕龄增加而增加,但是UM体积,并非随着雌、孕激素水平升高而相应增大。孕期母体产生的其他内分泌激素及羊膜腔张力、子宫收缩等因素,同样也影响着UM血供及生长方式。妊娠合并UM是一些不良妊娠结局的高危因素,如可能导致早产、胎盘早剥、产后出血等,同时也可增加剖宫产术分娩率。因此,本文拟结合国内外相关文献对妊娠合并UM在孕期的变化,及其与不良妊娠结局的关系进行综述如下,旨在提高临床医师对妊娠合并UM的认识,为临床正确管理妊娠合并UM提供思路。

Uterine myoma (UM) is the most common benign tumor of the female genital tract, which often occurs in their reproductive age, the cause has not been clarified so far, and its occurrence and development may be related to estrogen and progesterone. Although the levels of estrogen and progesterone produced in the placenta during pregnancy increases with the increase of gestational age, but the volume of UM does not increase with the increase of estrogen and progesterone levels. Other endocrine hormones produced by the body during pregnancy, and amniotic cavity tension, uterine contraction and other factors also affect the blood supply and growth mode of uterine myoma. Pregnancy complicated with UM is a high risk factor for some adverse pregnancy outcomes, such as premature delivery, placental abruption, postpartum hemorrhage etc., and also increases the rate of cesarean delivery. Therefore, this article combines relevant literature at domestic and abroad to analyze the changes of UM during pregnancy and their association with adverse pregnancy outcomes, to improve the clinical understanding of pregnancy with UM and to provide ideas for clinical correct management of pregnancy with UM.

[1]
Sobel M, Hobson S, Chan C. Uterine fibroids in pregnancy[J]. Can Med Assoc J, 2022, 194(22): e775. DOI: 10.1503/cmaj.211530.
[2]
Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids[J]. Int J Gynaecol Obstet, 2020, 149(1): 3-9. DOI: 10.1002/ijgo.13102.
[3]
Wang X, Wang G, Han R, et al. Uterine fibroids increase the risk of preterm birth and other adverse birth events: a systematic review and Meta-analysis[J]. Transl Pediatr, 2022, 11(6): 978-986. DOI: 10.21037/tp-22-215.
[4]
谢幸,孔北华,段涛,等. 妇产科学[M]. 9版. 北京:人民卫生出版社,2018: 303-306.
[5]
Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones and pathogenesis of uterine fibroids[J]. Best Pract Res Clin Obstet Gynaecol, 2016, 34: 13-24. DOI: 10.1016/j.bpobgyn.2015.11.015.
[6]
Landman AJEMC, Don EE, Vissers G, et al. The risk of preterm birth in women with uterine fibroids: a systematic review and Meta-analysis[J]. PLoS One, 2022, 17(6): e0269478. DOI: 10.1371/journal.pone.0269478.
[7]
Pandit U, Singh M, Ranjan R. Assessment of maternal and fetal outcomes in pregnancy complicated by fibroid uterus[J]. Cureus, 2022, 14(2): e22052. DOI: 10.7759/cureus.22052.
[8]
Yang Q, Al-Hendy A. Update on the role and regulatory mechanism of extracellular matrix in the pathogenesis of uterine fibroids[J]. Int J Mol Sci, 2023, 24(6): 5778. DOI: 10.3390/ijms24065778.
[9]
Yang Q, Ciebiera M, Bariani MV, et al. Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment[J]. Endocr Rev, 2022, 43(4): 678-719. DOI: 10.1210/endrev/bnab039.
[10]
Mitro SD, Peddada S, Chen Z, et al. Natural history of fibroids in pregnancy: national Institute of Child Health and Human Development Fetal Growth Studies - Singletons cohort[J]. Fertil Steril, 2022, 118(4): 656-665. DOI: 10.1016/j.fertnstert.2022.06.028.
[11]
Chill HH, Karavani G, Rachmani T, et al. Growth pattern of uterine leiomyoma along pregnancy[J]. BMC Women′s Heath, 2019, 19(1): 1-5. DOI: 10.1186/s12905-019-0803-5.
[12]
Laughlin SK, Herring AH, Savitz DA, et al. Pregnancy-related fibroid reduction[J]. Fertil Steril, 2010, 94(6): 2421-2423. DOI: 10.1016/j.fertnstert.2010.03.035.
[13]
Mesi Edzie EK, Dzefi-Tettey K, Brakohiapa EK, et al. Assessment of the clinical presentations and ultrasonographic features of uterine fibroids in adult africans: a retrospective study[J]. Oman Med J, 2023, 38(1): e459. DOI: 10.5001/omj.2023.36.
[14]
Sarais V, Cermisoni GC, Schimberni M, et al. Human chorionic gonadotrophin as a possible mediator of leiomyoma growth during pregnancy: molecular mechanisms[J]. Int J Mol Sci, 2017, 18(9): 2014. DOI: 10.3390/ijms18092014.
[15]
Delli Carpini G, Verdecchia V, Papiccio M, et al. Comparison of uterine fibroids′ growth pattern during pregnancy according to fetal sex: an observational study[J]. Biol Sex Differ, 2019, 10(1): 53. DOI: 10.1186/s13293-019-0266-2.
[16]
Reis-de-Carvalho C, Lopes J, Henriques A, et al. Management of pregnancy in case of multiple and giant uterine fibroids[J]. BMJ Case Rep, 2020, 13(11): e235572. DOI: 10.1136/bcr-2020-235572.
[17]
薛智方,吴跃芹,王细先,等. 子宫肌瘤患者孕产时并发症、分娩结局及新生儿结局分析[J]. 医学综述2018, 24(22): 4573-4576. DOI: 10.3969/j.issn.1006-2084.2018.22.039.
[18]
Delli Carpini G, Morini S, Papiccio M, et al. The association between childbirth, breastfeeding, and uterine fibroids: an observational study[J]. Sci Rep, 2019, 9(1): 10117. DOI: 10.1038/s41598-019-46513-0.
[19]
Farland LV, Stern JE, Liu CL, et al. Pregnancy outcomes among women with endometriosis and fibroids: registry linkage study in Massachusetts[J]. Am J Obstet Gynecol, 2022, 226(6): 829.e1-829.e14. DOI: 10.1016/j.ajog.2021.12.268.
[20]
Kim HJ, Lee J, Lee HJ. Differential diagnosis of uterine leiomyoma torsion mimicking ovarian torsion in a second trimester of pregnancy: a case report[J]. Int J Women′s Heath, 2022, 14: 1777-1782. DOI: 10.2147/ijwh.s385321.
[21]
Freytag D, Günther V, Maass N, et al. Uterine fibroids and infertility[J]. Diagnostics (Basel), 2021, 11(8): 1455. DOI: 10.3390/diagnostics11081455.
[22]
欧阳彦兰,曾喜群,黄燕婷,等. 妊娠合并子宫肌瘤孕妇先兆流产发生的危险因素[J]. 中国医药科学2021, 11(22): 145-148. DOI: 10.3969/j.issn.2095-0616.2021.22.039.
[23]
Datir SG, Bhake A. Management of uterine fibroids and its complications during pregnancy: a review of literature[J]. Cureus, 2022, 14(11): e31080. DOI: 10.7759/cureus.31080.
[24]
Hartmann KE, Velez Edwards DR, Savitz DA, et al. Prospective cohort study of uterine fibroids and miscarriage risk[J]. Am J Epidemiol, 2017, 186(10): 1140-1148. DOI: 10.1093/aje/kwx062.
[25]
Sundermann AC, Velez Edwards DR, Bray MJ, et al. Leiomyomas in pregnancy and spontaneous abortion: a systematic review and Meta-analysis[J]. Obstet Gynecol, 2017, 130(5): 1065-1072. DOI: 10.1097/AOG.0000000000002313.
[26]
Girault A, Le Ray C, Chapron C, et al. Leiomyomatous uterus and preterm birth: an exposed/unexposed monocentric cohort study[J]. Am J Obstet Gynecol, 2018, 219(4): 410.e1-410.e7. DOI: 10.1016/j.ajog.2018.08.033.
[27]
Ciavattini A, Clemente N, Delli Carpini G, et al. Number and size of uterine fibroids and obstetric outcomes[J]. J Matern Fetal Neonatal Med, 2015, 28(4): 484-488. DOI: 10.3109/14767058.2014.921675.
[28]
Karlsen K, Schiøler Kesmodel U, Mogensen O, et al. Relationship between a uterine fibroid diagnosis and the risk of adverse obstetrical outcomes: a cohort study[J]. BMJ Open, 2020, 10(2): e032104. DOI: 10.1136/bmjopen-2019-032104.
[29]
Zhao R, Wang X, Zou L, et al. Adverse obstetric outcomes in pregnant women with uterine fibroids in China: a multicenter survey involving 112, 403 deliveries[J]. PLoS One, 2017, 12(11): e0187821. DOI: 10.1371/journal.pone.0187821.
[30]
Coutinho LM, Assis WA, Spagnuolo-Souza A, et al. Uterine fibroids and pregnancy: how do they affect each other?[J]. Reprod Sci, 2022, 29(8): 2145-2151. DOI: 10.1007/s43032-021-00656-6.
[31]
Jenabi E, Fereidooni B. The uterine leiomyoma and placenta previa: a Meta-analysis[J]. J Matern Fetal Neonatal Med, 2019, 32(7): 1200-1204. DOI: 10.1080/14767058.2017.1400003.
[32]
王阳,赵岩. 初次妊娠患者发生前置胎盘的影响因素分析[J]. 中国医科大学学报2021, 50(5): 449-452. DOI: 10.12007/j.issn.0258-4646.2021.05.013.
[33]
Jenabi E, Ebrahimzadeh Zagami S. The association between uterine leiomyoma and placenta abruption: a Meta-analysis[J]. J Matern Fetal Neonatal Med, 2017, 30(22): 2742-2746. DOI: 10.1080/14767058.2016.1261401.
[34]
Harada T, Taniguchi F, Harada T. Increased risk of obstetric complications in patients with adenomyosis: a narrative literature review[J]. Reprod Med Biol, 2022, 21(1): e12473. DOI: 10.1002/rmb2.12473.
[35]
Jenabi E, Khazaei S. The effect of uterine leiomyoma on the risk of malpresentation and cesarean: a Meta-analysis[J]. J Matern Fetal Neonatal Med, 2018, 31(1): 87-92. DOI: 10.1080/14767058.2016.1275553.
[36]
王红梅,沈汝冈,杨惠娟,等. 双胎妊娠合并肌壁间子宫肌瘤孕妇剖宫产术时行肌瘤剔除术的安全性分析[J]. 中华妇产科杂志2022, 57(11): 843-849. DOI: 10.3760/cma.j.cn112141-20220721-00472.
[37]
路畅,胡江涛,李金皎,等. 剖宫产分娩中不同类型子宫肌瘤剔除术的临床特征分析[J]. 首都医科大学学报2022, 43(4): 653-657. DOI: 10.3969/j.issn.1006-7795.2022.04.022.
[38]
Lam SJ, Best S, Kumar S. The impact of fibroid characteristics on pregnancy outcome[J]. Am J Obstet Gynecol, 2014, 211(4): 395.e1-395.e5. DOI: 10.1016/j.ajog.2014.03.066.
[39]
路畅,胡江涛,王晓丹,等. 妊娠合并子宫肌瘤产科特征及妊娠结局临床分析[J]. 中国临床医生杂志2022, 50(10): 1221-1225. DOI: 10.3969/j.issn.2095-8552.2020.10.026.
[40]
Mitro SD, Sundaram R, Chen Z, et al. Leiomyomata, neonatal anthropometry, and pregnancy outcomes in singleton pregnancies[J]. Ann Epidemiol, 2023, 80: 43-52. DOI: 10.1016/j.annepidem.2023.02.008.
[41]
张红媛,顾永忠. 妊娠早期巨大子宫肌瘤术后分娩1例并文献复习[J]. 山东大学学报(医学版), 2023, 61(1): 69-73. DOI: 10.6040/j.issn.1671-7554.0.2022.0981.
[1] 李钱梅, 何冠南, 赵婧, 陈曦, 唐玉英, 马丽琼, 梁蓉, 袁桃, 李明星. 早孕期低危妊娠和高危妊娠胎盘微血流成像特征及预后分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 726-732.
[2] 钱警语, 郑明明. 《2024意大利妇产科学会非侵入性和侵入性产前诊断指南》解读[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 486-492.
[3] 张舒沁, 陈练. 产后宫腔内妊娠物残留的诊断和临床处理[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 493-497.
[4] 李霞林, 贺芳. 产后出血风险评估和早期预警系统[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 498-503.
[5] 费一鸣, 刘卓, 张丽娟. 组学分析在早产分子机制中的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 504-510.
[6] 刘子洋, 崔俭俭, 赵茵. 产科弥散性血管内凝血及其评分系统的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 511-518.
[7] 李小飞, 刘洪莉, 石丘玲, 田静, 李莉, 漆洪波, 罗欣. 自然分娩产妇低强度聚焦超声子宫复旧治疗防治产后出血的前瞻性随机对照研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 534-539.
[8] 黄蓉, 梁自毓, 祁文瑾. NLRP3炎症小体在胎膜早破孕妇血清中的表达及其意义[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 540-548.
[9] 何霞, 黄蓉, 祁文瑾. 胎膜早破孕妇胎盘与胎膜菌群丰度的高通量测序研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 549-555.
[10] 谢江燕, 王亚菲, 贺芳. 妊娠合并血栓性血小板减少性紫癜2例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 556-563.
[11] 张静, 刘畅, 华成舸. 妊娠期患者口腔诊疗进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(05): 340-344.
[12] 徐敬云, 丁波, 蒋宇慧, 沈杨. 妊娠期单孔腹腔镜手术实施行与思[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 262-266.
[13] 胡小靖, 张华. 妊娠期卵巢囊肿蒂扭转的诊断与治疗[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 197-201.
[14] 黎璞, 生秀杰. 妊娠合并子宫颈癌的管理[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 202-208.
[15] 俞慧慧, 尹宗智. 妊娠期胃穿孔[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 209-213.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?